MISSISSAUGA, ON, Nov. 10, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 antigen ...
Becton, Dickinson and Company BDX — also popularly known as BD — recently received CE mark for its rapid, point-of-care, SARS-CoV-2 antigen test for utilization on the BD Veritor Plus System. The new ...
BD (Becton, Dickinson and Company), a leading global medical technology company, announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor plus System has been CE marked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results